SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-11-013791
Filing Date
2011-03-09
Accepted
2011-03-09 17:04:48
Documents
9
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 v213588_10k.htm 10-K 2408774
2 GRAPHIC chart.jpg GRAPHIC 57698
3 v213588_ex21-1.htm EX-21.1 8520
4 v213588_ex23-1.htm EX-23.1 7590
5 v213588_ex23-2.htm EX-23.2 6289
6 v213588_ex31-1.htm EX-31.1 15147
7 v213588_ex31-2.htm EX-31.2 14223
8 v213588_ex32-1.htm EX-32.1 6614
9 v213588_ex32-2.htm EX-32.2 7002
  Complete submission text file 0001144204-11-013791.txt   2554683
Mailing Address
Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965
KERYX BIOPHARMACEUTICALS INC (Filer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30929 | Film No.: 11675806
SIC: 2834 Pharmaceutical Preparations